Overview

Lipid-lowering Therapy Individualization

Status:
Completed
Trial end date:
2019-08-27
Target enrollment:
Participant gender:
Summary
This clinical study will explore individual factors influencing statin pharmacokinetics in a cohort of 150 patients treated with atorvastatin.
Phase:
Phase 4
Details
Lead Sponsor:
Université Catholique de Louvain
Collaborator:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Treatments:
Atorvastatin
Atorvastatin Calcium